Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to compare the efficacy and safety of repeat doses of
intravenous (IV) ferumoxytol with IV iron sucrose for the treatment of IDA in subjects with
hemodialysis-dependent CKD.
Phase:
Phase 4
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Ferrosoferric Oxide Iron